Current trends in screening and secondary prevention of colorectal cancer

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1635-1640

  Crespi, M ^a   Stigliano, V ^a   Assisi, D ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Colorectal cancer screening; Genetic syndromes

Indexed keywords

AGE; ANAMNESIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; GENETIC DISORDER; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD; PEDIGREE; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SIGMOIDOSCOPY; WESTERN HEMISPHERE;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; MASS SCREENING; OCCULT BLOOD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

EID: 0035662198     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Estimates of the worldwide mortality from 25 cancers in 1990
2. La prevenzione secondaria del tumori del colonretto e del loro precursori
3. Trends in epidemiology of colorectal cancer
4. Colorectal cancer screening: An update
5. The National Polyp Study: Temporal sequence of evolving colorectal cancer from the normal colon
6. Prevention of colorectal cancer by colonoscopy polypectomy
7. Population-based surveillance by colonoscopy: Effect on the incidence of colorectal cancer
8. Colorectal cancer screening: Clinical guidelines and rationale
9. Immunochemical vs. guaiac faecal occult blood test in a population-based screening progamme for colorectal cancer
10. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing
11. Participation in mass screening for colorectal cancer: Results of screening and rescreening from the Burgundy study
12. How to perform the fecal occult blood test
13. Reducing mortality from colorectal cancer by screening for fecal occult blood
14. Randomised study of screening for colorectal cancer with fecal occult blood test at Funen in Denmark
15. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial
16. Screening for colorectal neoplasia. Commentary
17. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colanoscopy?
18. Randomised controlled trial of faecal occult blood screening for colorectal cancer
19. Randomized, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects
20. Evaluation of new occult blood tests for detection of colorectal neoplasia
21. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test Hemoccult
22. Hereditary non-polyposis colorectal cancer (Lynch syndromes I and II)
23. Sigmoidoscopy in the periodic health examination of asymptomatic adults
24. Patient response to sigmoidoscopy: A randomized controlled trial of rigid and flexible sigmoidoscopy
25. Screening flexible sigmoidoscopy: Patient attitudes and compliance
26. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas
27. Importance of adenomas 5mm or less in diameter that are detected by sigmoidoscopy
28. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
29. Protection by endoscopy against death from colorectal cancer
30. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy
31. UK randomised trial of once-only flexible sigmoidoscopy screening: Baseline results
32. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer
33. Colonoscopy as a mass screening tool
34. Computed tomography colonography (virtual colonoscopy): A new method for colorectal screening
35. Genetic testing in hereditary colorectal cancer: Indications and procedures
36. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
37. Endoscopic follow-up in oncological diseases of the gastrointestinal tract: The experience of the Regina Elena Cancer Institute
38. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years